Compare Oklo Inc (OKLO) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs Stryker Corporation — how do they compare? Oklo Inc trades at $34.7 (market cap $6.43B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 16.5× Oklo Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Oklo Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oklo Inc for 32 Days and Stryker Corporation for 21 Days on average.
| OKLO | SYK | |
|---|---|---|
Market Cap | $6.43B | $106.24B |
Volume | 16,238,368 | 2,982,001 |
Sector | Utilities | Health |
52-Week High | $174.14 | $388.35 |
52-Week Low | $34.57 | $269.75 |
Typical Hold Time | 32 Days | 21 Days |
Enterprise Value | $3.97B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $34.57, down 6.11% with bearish technical signals despite strong analyst support. The company shows no revenue in 2025 with significant losses (-$105.66M net income) and negative margins, though cash flow from financing provides runway. Recent news highlights nuclear sector volatility and OKLO's $1 billion stock sale raising dilution concerns.
Outlook hinges on project execution amid high risk-reward dynamics. Analyst consensus is bullish (71% Buy) with a $78.63 price target, but profitability challenges and cash burn pose substantial risks. Success depends on commercializing its nuclear reactor pipeline to capitalize on the growing AI power demand.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
